• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用不同肺部给药技术的小鼠呼吸道中微粒的沉积和分布模式

Respiratory Tract Deposition and Distribution Pattern of Microparticles in Mice Using Different Pulmonary Delivery Techniques.

作者信息

Kunda Nitesh K, Price Dominique N, Muttil Pavan

机构信息

Department of Pharmaceutical Sciences, College of Pharmacy, University of New Mexico Health Sciences Center, Albuquerque, NM 87102, USA.

出版信息

Vaccines (Basel). 2018 Jul 10;6(3):41. doi: 10.3390/vaccines6030041.

DOI:10.3390/vaccines6030041
PMID:29996506
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6161314/
Abstract

Pulmonary delivery of drugs and vaccines is an established route of administration, with particulate-based carriers becoming an attractive strategy to enhance the benefits of pulmonary therapeutic delivery. Despite the increasing number of publications using the pulmonary route of delivery, the lack of effective and uniform administration techniques in preclinical models generally results in poor translational success. In this study, we used the IVIS Spectrum small-animal in vivo imaging system to compare the respiratory tract deposition and distribution pattern of a microsphere suspension (5 µm) in mice after 1, 4, and 24 h when delivered by oropharyngeal aspiration, the Microsprayer Aerosolizer, and the BioLite Intubation System, three-widely reported preclinical inhalation techniques. We saw no significant differences in microsphere deposition in whole body images and excised lungs (at 1, 4, and 24 h); however, the three-dimensional (3D) images showed more localized deposition in the lungs with the MicroSprayer and BioLite delivery techniques. Further, oropharyngeal aspiration (at 1 h) showed microsphere deposition in the oral cavity, in contrast to the MicroSprayer and BioLite systems. The studies shown here will allow researchers to choose the appropriate pulmonary delivery method in animal models based on their study requirements.

摘要

药物和疫苗的肺部给药是一种既定的给药途径,基于颗粒的载体正成为增强肺部治疗给药益处的一种有吸引力的策略。尽管使用肺部给药途径的出版物数量不断增加,但临床前模型中缺乏有效且统一的给药技术通常导致转化成功率较低。在本研究中,我们使用IVIS Spectrum小动物体内成像系统,比较了通过口咽抽吸、微型喷雾器雾化器和BioLite插管系统(三种广泛报道的临床前吸入技术)给药后,微球悬浮液(5μm)在小鼠1小时、4小时和24小时后的呼吸道沉积和分布模式。我们在全身图像和切除的肺中(1小时、4小时和24小时)未观察到微球沉积有显著差异;然而,三维(3D)图像显示,使用微型喷雾器和BioLite给药技术时,肺部的沉积更局限。此外,与微型喷雾器和BioLite系统相比,口咽抽吸(1小时时)显示微球沉积在口腔中。此处所示的研究将使研究人员能够根据其研究需求在动物模型中选择合适的肺部给药方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92ef/6161314/61078c6435b4/vaccines-06-00041-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92ef/6161314/a1b14debef01/vaccines-06-00041-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92ef/6161314/8ef6915bedbc/vaccines-06-00041-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92ef/6161314/0e7181287f8f/vaccines-06-00041-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92ef/6161314/5ebf3aee2e35/vaccines-06-00041-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92ef/6161314/8102923a2830/vaccines-06-00041-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92ef/6161314/5e1682c10755/vaccines-06-00041-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92ef/6161314/73bb166b9582/vaccines-06-00041-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92ef/6161314/b26aa8c75eab/vaccines-06-00041-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92ef/6161314/61078c6435b4/vaccines-06-00041-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92ef/6161314/a1b14debef01/vaccines-06-00041-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92ef/6161314/8ef6915bedbc/vaccines-06-00041-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92ef/6161314/0e7181287f8f/vaccines-06-00041-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92ef/6161314/5ebf3aee2e35/vaccines-06-00041-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92ef/6161314/8102923a2830/vaccines-06-00041-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92ef/6161314/5e1682c10755/vaccines-06-00041-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92ef/6161314/73bb166b9582/vaccines-06-00041-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92ef/6161314/b26aa8c75eab/vaccines-06-00041-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92ef/6161314/61078c6435b4/vaccines-06-00041-g009.jpg

相似文献

1
Respiratory Tract Deposition and Distribution Pattern of Microparticles in Mice Using Different Pulmonary Delivery Techniques.使用不同肺部给药技术的小鼠呼吸道中微粒的沉积和分布模式
Vaccines (Basel). 2018 Jul 10;6(3):41. doi: 10.3390/vaccines6030041.
2
Comparison of the local pulmonary distribution of nanoparticles administered intratracheally to rats via gavage needle or microsprayer delivery devices.通过灌胃针或微喷雾器给药装置经气管内给予大鼠纳米颗粒后,其在肺部局部分布的比较。
J Appl Toxicol. 2017 Apr;37(4):502-507. doi: 10.1002/jat.3386. Epub 2016 Oct 6.
3
Preclinical evaluation of aerosol administration systems using Positron Emission Tomography.使用正电子发射断层扫描术对气溶胶给药系统进行临床前评估。
Eur J Pharm Biopharm. 2018 Sep;130:59-65. doi: 10.1016/j.ejpb.2018.05.037. Epub 2018 May 31.
4
Aerosol-Based Cell Therapy for Treatment of Lung Diseases.基于气雾剂的细胞疗法治疗肺部疾病
Methods Mol Biol. 2016;1516:243-255. doi: 10.1007/7651_2016_327.
5
CFD simulation of porous microsphere particles in the airways of pulmonary fibrosis.肺纤维化气道中多孔微球颗粒的 CFD 模拟。
Comput Methods Programs Biomed. 2022 Oct;225:107094. doi: 10.1016/j.cmpb.2022.107094. Epub 2022 Sep 2.
6
Inhalation Study of Mycobacteriophage D29 Aerosol for Mice by Endotracheal Route and Nose-Only Exposure.经气管内途径和仅经鼻暴露对小鼠进行分枝杆菌噬菌体D29气溶胶吸入研究。
J Aerosol Med Pulm Drug Deliv. 2016 Oct;29(5):393-405. doi: 10.1089/jamp.2015.1233. Epub 2016 Jan 8.
7
Evaluation of nose-only aerosol inhalation chamber and comparison of experimental results with mathematical simulation of aerosol deposition in mouse lungs.鼻用气雾剂吸入舱的评估以及实验结果与小鼠肺部气溶胶沉积数学模拟的比较。
J Pharm Sci. 2003 May;92(5):1066-76. doi: 10.1002/jps.10379.
8
A 3D printed human upper respiratory tract model for particulate deposition profiling.一种用于颗粒物沉积分析的 3D 打印人体上呼吸道模型。
Int J Pharm. 2021 Mar 15;597:120307. doi: 10.1016/j.ijpharm.2021.120307. Epub 2021 Feb 1.
9
Mouse pneumonia model by Acinetobacter baumannii multidrug resistant strains: Comparison between intranasal inoculation, intratracheal instillation and oropharyngeal aspiration techniques.鲍曼不动杆菌多重耐药株致小鼠肺炎模型的建立:滴鼻接种、气管内滴注和经口灌胃三种感染方法的比较。
PLoS One. 2021 Dec 2;16(12):e0260627. doi: 10.1371/journal.pone.0260627. eCollection 2021.
10
Respiratory Tract Deposition of HFA-Beclomethasone and HFA-Fluticasone in Asthmatic Patients.哮喘患者中HFA-倍氯米松和HFA-氟替卡松在呼吸道的沉积情况
J Aerosol Med Pulm Drug Deliv. 2016 Apr;29(2):127-33. doi: 10.1089/jamp.2014.1199. Epub 2015 Jun 10.

引用本文的文献

1
Comparative Evaluation of Lipopolysaccharide Administration Methods to Induce Acute Lung Injury in Murine Models: Efficacy, Consistency, and Technical Considerations.小鼠模型中诱导急性肺损伤的脂多糖给药方法的比较评估:有效性、一致性和技术考量
Crit Care Explor. 2025 Jul 28;7(8):e1292. doi: 10.1097/CCE.0000000000001292. eCollection 2025 Aug 1.
2
Nanotechnology-Based Therapeutics for Airway Inflammatory Diseases.基于纳米技术的气道炎症性疾病治疗方法
Clin Rev Allergy Immunol. 2025 Feb 10;68(1):12. doi: 10.1007/s12016-024-09019-w.
3
Optimizing anesthesia and delivery approaches for dosing into lungs of mice.

本文引用的文献

1
Delivery of Therapeutics to the Lung.向肺部输送治疗药物。
Methods Mol Biol. 2018;1809:415-429. doi: 10.1007/978-1-4939-8570-8_27.
2
Inhaled formulation and device selection: bridging the gap between preclinical species and first-in-human studies.吸入制剂与装置的选择:弥合临床前动物研究与首次人体研究之间的差距。
Ther Deliv. 2018 May;9(5):387-404. doi: 10.4155/tde-2000-0000.
3
Pulmonary administration of a dry powder formulation of the antifibrotic drug tilorone reduces silica-induced lung fibrosis in mice.肺部给予抗纤维化药物替洛隆干粉制剂可减少小鼠二氧化硅诱导的肺纤维化。
优化麻醉和分娩方法,以便将药物剂量递送至小鼠肺部。
Am J Physiol Lung Cell Mol Physiol. 2023 Aug 1;325(2):L262-L269. doi: 10.1152/ajplung.00046.2023. Epub 2023 Jul 4.
4
Aerosol pulmonary immune engineering.气溶胶肺部免疫工程。
Adv Drug Deliv Rev. 2023 Aug;199:114831. doi: 10.1016/j.addr.2023.114831. Epub 2023 Apr 24.
5
Inhalation of an RNA aptamer that selectively binds extracellular histones protects from acute lung injury.吸入一种能选择性结合细胞外组蛋白的RNA适体可预防急性肺损伤。
Mol Ther Nucleic Acids. 2023 Feb 24;31:662-673. doi: 10.1016/j.omtn.2023.02.021. eCollection 2023 Mar 14.
6
Carbon Nanotubes as Carriers in Drug Delivery for Non-Small Cell Lung Cancer, Mechanistic Analysis of Their Carcinogenic Potential, Safety Profiling and Identification of Biomarkers.碳纳米管作为非小细胞肺癌药物递送载体:致癌潜力的机制分析、安全性评估和生物标志物鉴定。
Int J Nanomedicine. 2022 Dec 8;17:6157-6180. doi: 10.2147/IJN.S384592. eCollection 2022.
7
Differential Biodistribution of Adenoviral-Vectored Vaccine Following Intranasal and Endotracheal Deliveries Leads to Different Immune Outcomes.经鼻内和气管内途径递送腺病毒载体疫苗导致不同的免疫结果。
Front Immunol. 2022 Jun 10;13:860399. doi: 10.3389/fimmu.2022.860399. eCollection 2022.
8
Method for Pulmonary Administration Using Negative Pressure Generated by Inspiration in Mice.利用小鼠吸气产生的负压进行肺部给药的方法。
Pharmaceutics. 2020 Feb 25;12(3):200. doi: 10.3390/pharmaceutics12030200.
Int J Pharm. 2018 Jun 10;544(1):121-128. doi: 10.1016/j.ijpharm.2018.04.019. Epub 2018 Apr 12.
4
Polymer-Lipid Microparticles for Pulmonary Delivery.聚合物-脂质微粒用于肺部递药。
Langmuir. 2018 Mar 20;34(11):3438-3448. doi: 10.1021/acs.langmuir.7b03645. Epub 2018 Mar 9.
5
Mucosal immunization with PspA (Pneumococcal surface protein A)-adsorbed nanoparticles targeting the lungs for protection against pneumococcal infection.用吸附肺炎球菌表面蛋白A(PspA)的纳米颗粒进行黏膜免疫,靶向肺部以预防肺炎球菌感染。
PLoS One. 2018 Jan 23;13(1):e0191692. doi: 10.1371/journal.pone.0191692. eCollection 2018.
6
Inhalable particulate drug delivery systems for lung cancer therapy: Nanoparticles, microparticles, nanocomposites and nanoaggregates.可吸入颗粒药物传递系统治疗肺癌:纳米粒子、微粒子、纳米复合材料和纳米聚集体。
J Control Release. 2018 Jan 10;269:374-392. doi: 10.1016/j.jconrel.2017.11.036. Epub 2017 Nov 24.
7
In Vivo Pulmonary Delivery and Magnetic-Targeting of Dry Powder Nano-in-Microparticles.体内肺部递药和干粉型纳米-微球的磁靶向
Mol Pharm. 2017 Dec 4;14(12):4741-4750. doi: 10.1021/acs.molpharmaceut.7b00532. Epub 2017 Nov 9.
8
Pulmonary Delivery of Magnetically Targeted Nano-in-Microparticles.磁性靶向微纳复合粒子的肺部给药
Methods Mol Biol. 2017;1530:369-378. doi: 10.1007/978-1-4939-6646-2_23.
9
Oropharyngeal aspiration of bleomycin: An alternative experimental model of pulmonary fibrosis developed in Swiss mice.博来霉素的口咽吸入:在瑞士小鼠中建立的肺纤维化替代实验模型。
Indian J Pharmacol. 2016 Nov-Dec;48(6):643-648. doi: 10.4103/0253-7613.194859.
10
Synthetic Biodegradable Microparticle and Nanoparticle Vaccines against the Respiratory Syncytial Virus.针对呼吸道合胞病毒的合成可生物降解微粒和纳米颗粒疫苗。
Vaccines (Basel). 2016 Dec 2;4(4):45. doi: 10.3390/vaccines4040045.